FDA Drug Approval Marks a First for a Disease — But It’s Not Autism
The FDA made waves with its recent announcement a single well-controlled Phase 3 study would suffice for a drug submission, replacing the previous standard of two pivotal studies. This past week, the FDA granted a drug approval without any new clinical …